PFE Price Prediction Next Week
Based on the provided data and current market conditions, here's a comprehensive analysis for PFE's price movement in the next trading week:
Technical Analysis
The technical indicators show:
- RSI (14) at 53.50 indicates neutral momentum
- MACD shows slight bearish divergence at -0.14
- Price is trading above both 5-day SMA ($25.84) and 10-day SMA ($25.74)
- Bollinger Bands (20,3) show:
- Upper band: $27.45
- Middle band: $26.08
- Lower band: $24.70
- Current price position suggests room for upward movement
News Sentiment Analysis
- Positive catalysts:
- High rating (90%) from Validea's Earnings Yield Investor model
- Strong earnings growth potential of 14% annually over next 3-5 years
- Attractive valuation with PEG ratio of 0.6, indicating the stock is undervalued
- Potential headwinds:
- Recent Trump administration warnings about pharmaceutical tariffs
- Medicare price negotiation program impact
Price Target Forecast Based on technical and fundamental factors:
- Support levels: $25.83, $25.52
- Resistance levels: $26.44, $26.96
- Next week's predicted trading range: $25.77 - $26.83
Trading Recommendation BUY with target entry at current levels ($26.30):
- Short-term price target: $26.83 (+2.0%)
- Stop loss: $25.77 (-2.0%)
Rationale:
- Multiple positive technical signals showing potential upward momentum
- Strong fundamental backing with expected 14% annual earnings growth
- Current price offers attractive entry point with favorable risk/reward ratio
- Positive analyst consensus with average price target of $30.93
The stock shows a favorable setup with controlled movements and good liquidity, suggesting very low risk for the recommended trade setup. The positive momentum indicators combined with strong fundamental factors support an upward movement in the coming week.
PFE Similar Chart Price Prediction
The price of PFE is predicted to go up 8.61%, based on the high correlation periods with CABA. The similarity of these two price pattern on the periods is 92.44%.
PFE
CABA
Up: 8.61%Similarity: 92.44%
PFE Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030
Year
PFE Price Forecast($)
Potential Return(%)
2025
26.730
0.530
2026
29.000
9.350
2027
35.000
31.980
2028
35.000
31.980
2029
35.000
31.980
2030
35.000
31.980
What is PFE stock price prediction 2025 ?
What is PFE stock price prediction 2026 ?
What is PFE stock price prediction 2027 ?
What is PFE stock price prediction 2028 ?
What is PFE stock price prediction 2029 ?
What is PFE stock price prediction 2030 ?
PFE Revenue Forecast
PFE EPS Forecast
PFE FAQs
What is bull’s view on PFE?
What is bear's view on PFE?
What is PFE revenue forecast for next quarter？
What is PFE eps forecast for next quarter？
PFE VS S&P500
Pfizer's pipeline productivity is improving with several successful recent drug launches. In particular, cardiovascular drug Vyndaqel is a potential game-changer in the rare-disease arena.
Pfizer's strong success in developing a COVID-19 vaccine and treatment is yielding a massive cash windfall.
Pfizer's decision to divest its off-patent division should result in a faster-growing, innovative company.
PFE Analyst's Forecast
Colin Bristow
UBS
Hold
2025-01-08
Price Target
$31 → $29
Upside
+7.97%
UBS lowered the firm's price target on Pfizer to $29 from $31 and keeps a Neutral rating on the shares as part of a broader note on the U.S. Pharmaceuticals and Biotechnology industry. The firm believes BioPharma will find it difficult to outperform against a more uncertain macro backdrop in the short-term, and thinks President-elect Trump will be capable of enacting significant legislative change, and that unpredictability is expected to cast a shadow over the space, the analyst tells investors in a research note. There will be continued uncertainty in the space until there is more clarity on Trump's changes, UBS says.
Tim Anderson
B of A Securities
Hold
2024-12-10
Price Target
$29
Upside
+13.41%
Alexandria Hammond
Wolfe Research
Sell
2024-11-15
Price Target
$25
Upside
+0.81%
